EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation

Yizi Wang, Yutao Wang, Cheng Zhang, Danyang Li, Xun Fu, Tuan Wang, Lingxiao Zhang, Yun Wang

Acta Biomaterialia · 2026-10 · 223 · 59-82

DOI: 10.1016/j.actbio.2026.08.033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von Yizi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Zinc, Nucleotidyltransferases. Die Arbeit nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy has substantially advanced cancer treatment; however, durable responses remain uncommon in tumors with low immunogenicity and strongly suppressive tumor microenvironments (TME). Among innate immune pathways, cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) signaling has attracted considerable attention because of its ability to initiate broad antitumor immune responses. Despite this promise, the therapeutic use of STING agonists is limited by rapid systemic clearance, insufficient tumor accumulation, and dose-limiting inflammatory toxicity. Simultaneously, metabolic adaptations within tumors, including elevated glycolytic flux, lactate enrichment, and redox imbalance, continue to undermine immune cell function and restrict treatment efficacy. Zn-based nanoplatforms have recently emerged as versatile systems capable of simultaneously addressing both challenges. Controlled intracellular release of Zn2+ can potentiate cGAS activity and strengthen downstream STING signaling, whereas oxidative stress induced by these nanomaterials promotes DNA damage, cytosolic DNA leakage, and immunogenic cell death. These effects are not limited to the activation of innate immunity. Several Zn-containing nanoplatforms reshape the metabolic landscape of the TME by lowering lactate accumulation and partially restoring immune cell activity. Consequently, dendritic cell (DC) maturation and antigen presentation are enhanced, leading to more effective T cell-driven antitumor responses. This review examines the emerging role of Zn2+ in regulating the immune and metabolic pathways relevant to cancer therapy. We discuss current strategies for designing Zn-based nanoplatforms, with particular emphasis on the mechanisms linking metabolic intervention to cGAS-STING activation. Dedicated sections examine Zn-based platforms for drug delivery and photodynamic and sonodynamic therapies, as well as their capacity to promote DC activation and combination immunotherapy. Finally, we consider the major barriers to clinical translation, including biosafety, delivery efficiency, and large-scale manufacturing, and outline the directions for the development of next-generation Zn-based immunotherapeutic systems. STATEMENT OF SIGNIFICANCE: This review provides a comprehensive, mechanistically integrated perspective on Zn-based nanoplatforms as multifunctional immunotherapeutic systems that bridge tumor metabolic reprogramming and cGAS-STING-mediated innate and adaptive immune activation. Unlike previous reviews that primarily focused on STING agonists or Zn-based nanomaterials independently, this study highlights how tumor-responsive Zn²⁺ release, oxidative stress, DNA damage, and metabolic remodeling collectively enhance antitumor immunity. This review critically compares the design principles, therapeutic mechanisms, and translational potential of diverse Zn-based nanoplatforms and discusses the key challenges in biosafety, manufacturing, and clinical translation. This review offers a conceptual framework to guide the rational development of next-generation Zn-based nanomedicines for precision cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsZincNucleotidyltransferasesNanoparticlesMembrane ProteinsHumansAnimalscGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseSignal TransductionSTING ProteinImmunity, Innate

Stichwörter der Autor:innen

Cancer immunotherapyDCsInnate immunityNanomedicineTumor metabolismZn-based nanoplatformscGAS-STING pathway

Substanzen

ZincCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseNucleotidyltransferasesMembrane ProteinsSTING Protein

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
  • Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100000, China.
  • Department of Pancreatic and Biliary Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
  • Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, 150081, China.
  • Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, 110001, China. Electronic address: twang1826@sina.com.
  • Interdisciplinary Nanoscience Center, Aarhus University, Aarhus C, 8000, Denmark. Electronic address: zhanglx@inano.au.dk.

Förderung

  • Horizon 2020

Zitieren

APA

Wang, Y., Wang, Y., Zhang, C., Li, D., Fu, X., Wang, T., Zhang, L., & Wang, Y. (2026). Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation. Acta Biomaterialia, 223, 59-82. https://doi.org/10.1016/j.actbio.2026.08.033

Vancouver

Wang Y, Wang Y, Zhang C, Li D, Fu X, Wang T, et al. Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation. Acta Biomaterialia. 2026;223:59-82. doi:10.1016/j.actbio.2026.08.033

BibTeX
@article{Wang2026,
  author = {Wang, Yizi and Wang, Yutao and Zhang, Cheng and Li, Danyang and Fu, Xun and Wang, Tuan and Zhang, Lingxiao and Wang, Yun},
  title = {Zinc-based nanoplatforms for cancer immunotherapy achieved through the cyclic GMP-AMP synthase-stimulator of interferon genes pathway: Bridging tumor metabolism and immune activation},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {223},
  pages = {59--82},
  doi = {10.1016/j.actbio.2026.08.033}
}
Kostenlos starten →